AFAP1L1 was shown to play a role in tumour metastasis and to constitute a cancer prognostic marker (Furu et al., 2011), to be localised to invadosomes and along with cortactin, to podosomes (Snyder et al., 2011). Here, AFAP1L1 is linked to neoplasm.